Evaluation of a Keratin 1 Targeting Peptide-Doxorubicin Conjugate in a Mouse Model of Triple-Negative Breast Cancer

Chemotherapy is the main treatment for triple-negative breast cancer (TNBC), a subtype of breast cancer that is aggressive with a poor prognosis. While chemotherapeutics are potent, these agents lack specificity and are equally toxic to cancer and nonmalignant cells and tissues. Targeted therapies f...

Descripción completa

Detalles Bibliográficos
Autores principales: Saghaeidehkordi, Azam, Chen, Shiuan, Yang, Sun, Kaur, Kamaljit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148172/
https://www.ncbi.nlm.nih.gov/pubmed/34063098
http://dx.doi.org/10.3390/pharmaceutics13050661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148172/
https://www.ncbi.nlm.nih.gov/pubmed/34063098
http://dx.doi.org/10.3390/pharmaceutics13050661

Ejemplares similares